Genomix Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Ranchi, Jharkhand, India, established in 2011.
2011 Ranchi, Jharkhand, India Active
Last Updated:
Access Report
About Genomix Pharmaceuticals Private Limited

Genomix Pharmaceuticals Private Limited, a active private limited company, was established on 17 February 2011 in Ranchi, Jharkhand, India. Engaging in wholesale within the trade sector, it holds CIN: U51909JH2011PTC014694. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.80 M.

It upholds a compliant status. Its leadership includes Rupa Kumari Gupta (Director), Mira Gupta (Director), Mrinal Kumar Gupta (Director). Past directors included Rupa Kumari Gupta, Prabhat Kumar Sahu. It holds ₹5.00 M open charges and ₹2.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Dinbandhu Lane Upper Bazar, Ranchi, Jharkhand, 834001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909JH2011PTC014694

  • Registration Number

    014694

  • Incorporation Date

    17 February 2011

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹1.80 M

  • ROC Code

    Roc Ranchi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 1.80 M
  • Company Age 14 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.00 M
  • Satisfied Charges ₹ 2.50 M
Company report

Genomix Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genomix Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Genomix Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rupa Kumari Gupta Director 17 Jun 2020 Current
Mira Gupta Director 25 Jun 2013 Current
Mrinal Kumar Gupta Director 17 Feb 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Apr 2021 Past
Pramod Abcsdd Director 25 Jun 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genomix Pharmaceuticals.

Genomix Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Genomix Pharmaceuticals revenue growth over time
Genomix Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genomix Pharmaceuticals?

In 2017, Genomix Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,000,000.00

Satisfied Charges

₹2,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.50 Cr
Latest Charge Details
Date Lender Amount Status
11 Sep 2020 Others ₹5.00 M Open
12 May 2016 Others ₹2.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Genomix Pharmaceuticals?

Unlock and access historical data on people associated with Genomix Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genomix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomix Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genomix Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Genomix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Genomix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi. was documented.

  • Charges

    A charge with Others amounted to Rs. 5.00 M with Charge ID 100375377 was registered on 11 Sep 2020. was recorded as a recent event.

  • Director Appointment

    Progress on Rupa Kumari Gupta was appointed as a Director was appointed as a Director on 17 Jun 2020 & has been associated with this company since 5 years 7 months . was documented.

  • Charges

    The activity A charge registered on 12 May 2016 via Charge ID 100029228 with Others was fully satisfied on 29 Aug 2019. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 2.50 M with Charge ID 100029228 was registered on 12 May 2016. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genomix Pharmaceuticals Private Limited?

The CIN of Genomix Pharmaceuticals Private Limited is U51909JH2011PTC014694.

Where is Genomix Pharmaceuticals Private Limited headquartered?

Genomix Pharmaceuticals Private Limited is headquartered at Dinbandhu Lane Upper Bazar, Ranchi, Jharkhand, 834001.

When was Genomix Pharmaceuticals Private Limited incorporated?

Genomix Pharmaceuticals Private Limited was incorporated on 17 February 2011.

Who are the current directors of Genomix Pharmaceuticals Private Limited?

The current directors of Genomix Pharmaceuticals Private Limited are

What is the primary industry of Genomix Pharmaceuticals Private Limited?

The primary industry of Genomix Pharmaceuticals Private Limited is Trade.

Is Genomix Pharmaceuticals Private Limited a listed company?

Genomix Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Genomix Pharmaceuticals Private Limited?

The authorized capital of Genomix Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹1.80 M.

What is the compliance status of Genomix Pharmaceuticals Private Limited?

The compliance status of Genomix Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available